THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [**********] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Amendment No. 1 To the LICENSE AGREEMENTLicense Agreement • August 6th, 2010 • Novavax Inc • Biological products, (no disgnostic substances)
This Amendment is effective as of March 17, 2010 and amends the License Agreement dated as of July 5, 2007 (the “Agreement”), by and between Wyeth Holdings Corporation, having a place of business at Five Giralda Farms, Madison, New Jersey 07940 (“Wyeth”), and Novavax, Inc., having its principal place of business at 9920 Belward Campus Drive, Rockville, Maryland 20850 (“Novavax”).
CONSULTING AGREEMENTConsulting Agreement • August 6th, 2010 • Novavax Inc • Biological products, (no disgnostic substances) • Maryland
THIS CONSULTING AGREEMENT (this “Agreement”) is made as of April 1, 2010, by and between Novavax, Inc. (“Novavax”), having a place of business at 9920 Belward Campus Drive, Rockville, Maryland 20850, and John Lambert, residing at Box Cottage, Church Lane, Great Kimble, Aylesbury, Bucks UK HP17 9TH (the “Consultant”).
